Lessons From The Pharma Industry On Patent Cliffs
The pharmaceutical industry will spend the next five years hurtling toward 2030's multibillion-dollar patent cliff, when patents for blockbuster drugs including Eliquis,[1] Keytruda and Stelara[2] will expire....To view the full article, register now.
Already a subscriber? Click here to view full article